BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dunn AL, Michie PT, Hodgson DM, Harms L. Adolescent cannabinoid exposure interacts with other risk factors in schizophrenia: A review of the evidence from animal models. Neurosci Biobehav Rev 2020;116:202-20. [PMID: 32610181 DOI: 10.1016/j.neubiorev.2020.06.028] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Jalewa J, Todd J, Michie PT, Hodgson DM, Harms L. The effect of schizophrenia risk factors on mismatch responses in a rat model. Psychophysiology 2023;60:e14175. [PMID: 36087044 DOI: 10.1111/psyp.14175] [Reference Citation Analysis]
2 Zainab A, Shabbir D, Waqar K, Mehmood A. Consumption of Cannabis: A Risk Factor or a Therapeutic Agent for Patients with Schizophrenia. Cognizance of Schizophrenia:: A Profound Insight into the Psyche 2023. [DOI: 10.1007/978-981-19-7022-1_15] [Reference Citation Analysis]
3 Scheyer AF, Laviolette SR, Pelissier A, Manzoni OJ. Cannabis in Adolescence: Lasting Cognitive Alterations and Underlying Mechanisms. Cannabis and Cannabinoid Research 2022. [DOI: 10.1089/can.2022.0183] [Reference Citation Analysis]
4 Stark T, Di Martino S, Drago F, Wotjak CT, Micale V. Phytocannabinoids and schizophrenia: Focus on adolescence as a critical window of enhanced vulnerability and opportunity for treatment. Pharmacol Res 2021;174:105938. [PMID: 34655773 DOI: 10.1016/j.phrs.2021.105938] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
5 De Felice M, Laviolette SR. Reversing the Psychiatric Effects of Neurodevelopmental Cannabinoid Exposure: Exploring Pharmacotherapeutic Interventions for Symptom Improvement. Int J Mol Sci 2021;22:7861. [PMID: 34360626 DOI: 10.3390/ijms22157861] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Corsi-Zuelli F, Marques L, da Roza DL, Loureiro CM, Shuhama R, Di Forti M, Menezes PR, Louzada-Junior P, Del-Ben CM. The independent and combined effects of cannabis use and systemic inflammation during the early stages of psychosis: exploring the two-hit hypothesis. Psychol Med 2021;:1-11. [PMID: 33736715 DOI: 10.1017/S0033291721000726] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
7 Percelay S, Billard JM, Freret T, Andrieux A, Boulouard M, Bouet V. Functional Dysregulations in CA1 Hippocampal Networks of a 3-Hit Mouse Model of Schizophrenia. Int J Mol Sci 2021;22:2644. [PMID: 33807989 DOI: 10.3390/ijms22052644] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]